Previsioni di mercato per la terapia dell\'osteoartrosi in Europa fino al 2030 - Analisi regionale - per tipo di terapia (stimolazione elettrica transcutanea dei nervi (TENS), terapia occupazionale, terapia fisica, terapia con plasma ricco di piastrine e frazione vascolare stromale, proloterapia e altre), indicazione della malattia (osteoartrite del ginocchio , osteoartrosi della colonna vertebrale, artrosi del piede e della caviglia, osteoartrosi della spalla, artrosi della mano e altri) e utente finale (ospedali e cliniche, cliniche specialistiche, centri chirurgici ambulatoriali, assistenza domiciliare e altri)
La disponibilità della medicina rigenerativa guida il mercato europeo della terapia per l\'osteoartrosi
La medicina rigenerativa è un\'alternativa nuova e potenzialmente trasformativa alle opzioni terapeutiche tradizionali per trattare l\'OA. La medicina rigenerativa utilizza ingegneria biomedica, biomateriali e terapie cellulari che prendono di mira il sistema immunitario del corpo per trattare l’OA. Inoltre, i ricercatori clinici hanno sviluppato metodi per riparare la cartilagine articolare dei pazienti utilizzando le cellule dei pazienti (autologhe). Inoltre, le opzioni di terapia rigenerativa utilizzano \"l\'impianto di condrociti autologhi indotti dalla matrice (MACI)\". MACI può riparare piccole aree di cartilagine, prevenendo o ritardando l\'OA. Inoltre, diversi produttori stanno sviluppando prodotti focalizzati sulla terapia rigenerativa. La crescente inclinazione verso approcci non chirurgici come la terapia PRP, la terapia con cellule staminali, le iniezioni di acido ialuronico e la proloterapia spingerebbe l’adozione della medicina rigenerativa. I pazienti affetti da OA possono essere trattati utilizzando terapie non farmacologiche. Le opzioni di terapia rigenerativa possono migliorare le funzioni articolari riducendo in definitiva il dolore e migliorando la qualità complessiva della vita delle persone affette da OA. Pertanto, si prevede che la crescente adozione della medicina rigenerativa aprirà nuove opportunità commerciali nel mercato della terapia dell’osteoartrosi durante il periodo di previsione.
Panoramica del mercato della terapia per l\'osteoartrite in Europa
Il mercato della terapia per l\'osteoartrosi in Europa è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. Le rapide approvazioni di prodotti nella regione per i farmaci per il trattamento dell’osteoartrosi e le infrastrutture sanitarie avanzate sono i fattori più influenti responsabili della crescita del mercato. Secondo il rapporto del Journal of Health Monitoring, l’artrosi è la malattia articolare più comune in Germania. Il dolore articolare e la perdita di funzionalità possono comportare una perdita della qualità della vita poiché l\'osteoartrite è causata negli arti superiori (dita, mani e spalle). Pertanto, con l’invecchiamento della popolazione tedesca, la prevalenza dell’osteoartrosi continuerà ad aumentare, con un conseguente onere elevato per il sistema sanitario. Secondo il rapporto dell’Organizzazione Mondiale della Sanità (OMS) pubblicato nel 2020, i decessi per osteoartrite in Germania rappresentano lo 0,05% del totale dei decessi. Inoltre, il lancio di nuovi prodotti favorisce la crescita del mercato. Ad esempio, nel maggio 2023, Grünenthal ha annunciato di aver ricevuto l\'approvazione per il medicinale sperimentale non oppioide \"Resiniferatoxin (RTX)\", attualmente in fase di sviluppo clinico di fase 3, che rappresenta una terapia rivoluzionaria da parte della Food and Drug Administration (USFDA) statunitense per il trattamento dell\'artrosi del ginocchio. La resiniferatossina può diventare un’opzione terapeutica non oppioide significativa, fornendo sollievo dal dolore duraturo e miglioramento funzionale dell’articolazione colpita.
Entrate e previsioni del mercato europeo della terapia per l\'osteoartrosi fino al 2030 (milioni di dollari)
Segmentazione del mercato europeo della terapia per l\'osteoartrite
Il mercato europeo della terapia per l\'osteoartrosi è classificato in tipo di terapia, indicazioni di malattia , utente finale e paese.
In base al tipo di terapia, il mercato europeo della terapia per l\'osteoartrosi è segmentato in stimolazione nervosa elettrica transcutanea (TENS), terapia occupazionale, terapia fisica, terapia con plasma ricco di piastrine (PRP) e frazione vascolare stromale, proloterapia e altre . Il segmento della terapia fisica ha detenuto la quota di mercato maggiore nel 2022.
In termini di indicazioni patologiche, il mercato europeo della terapia per l\'osteoartrite è segmentato in osteoartrite del ginocchio, osteoartrite della colonna vertebrale, osteoartrite del piede e della caviglia, osteoartrite della spalla, osteoartrite della mano e altri. Il segmento dell\'osteoartrosi del ginocchio ha detenuto la quota maggiore del mercato europeo della terapia per l\'osteoartrosi nel 2022.
In base agli utenti finali, il mercato europeo della terapia per l\'osteoartrosi è classificato in ospedali e cliniche, cliniche specialistiche, centri chirurgici ambulatoriali, assistenza domiciliare e altri . Il segmento dell\'assistenza domiciliare deteneva la quota maggiore del mercato europeo della terapia per l\'osteoartrosi nel 2022.
Per paese, il mercato europeo della terapia per l\'osteoartrosi è segmentato in Regno Unito, Germania, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato la quota di mercato europea della terapia per l\'osteoartrosi nel 2022.
Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc e Medi GmbH & Co KG sono alcune delle aziende leader che operano in il mercato europeo della terapia dell’osteoartrosi.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Europe Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Europe Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Osteoarthritis Therapy Market - Country Analysis
10.1 Europe Market Overview
10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 Zimmer Biomet Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DePuy Synthes Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bioventus Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Omron Healthcare Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Exactech Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy market
1. Zimmer Biomet Holdings Inc
2. DePuy Synthes Inc
3. Bioventus Inc
4. Omron Healthcare Inc
5. Exactech Inc
6. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.